InMode (INMD) Beginning Cash Balance (2018 - 2026)
InMode (INMD) posted quarterly Beginning Cash Balance of $302.5 million for Q1 2026, up 94.78% year-on-year from $155.3 million in Q1 2025, and up 39.91% on a QoQ basis from $216.2 million in Q3 2025.
InMode (INMD) Beginning Cash Balance (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Beginning Cash Balance for 9 consecutive years, with $302.5 million the latest figure, recorded in Q1 2026.
- Quarterly Beginning Cash Balance rose 94.78% year-over-year to $302.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $820.1 million (up 59.96% YoY) and the FY2023 annual result came in at $97.5 million, up 43.15% from the prior year.
- Beginning Cash Balance advanced to $302.5 million in Q1 2026 per INMD's latest filing, from $216.2 million in the prior quarter.
- Over the last five years, Beginning Cash Balance for INMD reached as high as $302.5 million in Q1 2026 and fell as low as $44.7 million in Q2 2022.
- A 5-year average of $129.3 million and a median of $120.9 million in 2024 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2024 — Beginning Cash Balance plunged 42.45% — and 2025, when it soared 135.05%.
- Year by year, Beginning Cash Balance stood at $77.0 million in 2022, then surged by 73.57% to $133.7 million in 2023, then plunged by 31.21% to $92.0 million in 2024, then soared by 135.05% to $216.2 million in 2025, then soared by 39.91% to $302.5 million in 2026.
- According to Business Quant data, Beginning Cash Balance over the past three periods registered $302.5 million, $216.2 million, and $145.9 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 302.54 Mn |
| Mar 31, 2026 | 302.54 Mn |
| Sep 30, 2025 | 216.24 Mn |
| Sep 30, 2025 | 216.24 Mn |
| Jun 30, 2025 | 145.95 Mn |
| Jun 30, 2025 | 145.95 Mn |
| Mar 31, 2025 | 155.33 Mn |
| Mar 31, 2025 | 155.33 Mn |
| Sep 30, 2024 | 92.00 Mn |
| Sep 30, 2024 | 92.00 Mn |
| Jun 30, 2024 | 120.93 Mn |
| Jun 30, 2024 | 120.93 Mn |
| Mar 31, 2024 | 144.41 Mn |
| Mar 31, 2024 | 144.41 Mn |
| Dec 31, 2023 | 133.73 Mn |
| Dec 31, 2023 | 133.73 Mn |
| Sep 30, 2023 | 159.86 Mn |
| Sep 30, 2023 | 159.86 Mn |
| Jun 30, 2023 | 92.96 Mn |
| Jun 30, 2023 | 92.96 Mn |